The US AI research company Anthropic has become known for building powerful AI models while simultaneously warning about ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Singapore's Minister for Health Ong Ye Kung has called on governments and industry to take a deliberate, humanistic stance on ...

Intactis Bio joins the Biocomputing industry, which seeks to deliver lower-energy, cost-efficient computing capacity driven ...

Biopharma companies won’t fully capture the benefits of AI unless they reorganize their R&D units, according to McKinsey.

OpenAI’s expanding robotics and simulation efforts signal that embodied AI is becoming the next frontier, strengthening the ...

These days, the frontier AI labs are all racing to build self-improving models. Some believe it’s the surest route to ...

As they scramble to keep their systems online, AI companies are making things expensive for the rest of us. Large language ...

It’s become a trope in Silicon Valley to liken the rise of AI to t. Hardcore AI true-believers often say that the rise of ...

This past summer has seen major updates in the burgeoning relationship between the U.S. government and developers of the ...

I know I’m old because I remember when a B+ was a respectable grade. Now it’s more like an indictment. I’m a masochist if I ...

At the moment, many of the big AI systems used in drug discovery are closed-source, meaning they are proprietary and carry an ...